Overview

Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Status:
Completed
Trial end date:
2017-12-27
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled crossover study to assess the effect of inorganic nitrite (NO2) on aerobic capacity (peak VO2) after four weeks of dosing. Approximately 100 participants will be enrolled in this 2*2 crossover study.
Phase:
Phase 2
Details
Lead Sponsor:
Adrian Hernandez
Collaborators:
Aires Pharmaceuticals, Inc.
Massachusetts General Hospital
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)
Université de Montréal
University of Vermont